Ferrylmyoglobin impairs secretion of VLDL triacylglycerols from stored intracellular pools: Involvement of lipid peroxidation

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 5, 2007, Pages 590-599

  Martínez, Rosa ^a   Lacort, Mercedes ^a   Ruiz Sanz, José Ignacio ^a   Ruiz Larrea, M Begoña ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Apolipoprotein B; Lipid peroxidation; Triacylglycerol synthesis, diacylglycerol: acylCoA acyltransferase; VLDL

Indexed keywords

ACYL COENZYME A; ACYLTRANSFERASE; ALPHA TOCOPHEROL; APOLIPOPROTEIN B; FERRYLMYOGLOBIN; HEMOPROTEIN; OLEIC ACID; PROMETHAZINE; TRANSFERRIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ESTERIFICATION; IMMUNODETECTION; LIPID PEROXIDATION; LIPID TRANSPORT; LIPOGENESIS; LIPOLYSIS; LIVER CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANIMALS; APOLIPOPROTEIN B-100; DIGLYCERIDES; KINETICS; LIPID PEROXIDATION; LIPIDS; LIPOPROTEINS, VLDL; LIVER; MALE; METMYOGLOBIN; RATS; RATS, SPRAGUE-DAWLEY; TRANSFERRIN; TRIGLYCERIDES;

RATTUS;

EID: 34247642295     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.03.008     Document Type: Article

References (54)

1. Pietri S., Seguin J.R., d'Arbigny P.D., and Culcasi M. Ascorbyl free radical: a noninvasive marker of oxidative stress in human open-heart surgery. Free Radic. Biol. Med. 16 (1994) 523-528
2. Zager R.A. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 49 (1996) 314-326
3. Moore K.P., Holt S.G., Patel R.P., Svistunenko D.A., Zackert W., Goodier D., Reeder B.J., Clozel M., Anand R., Cooper C.E., Morrow J.D., Wilson M.T., Darley-Usmar V., Roberts L.J., and Abassi Z.A. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J. Biol. Chem. 273 (1998) 31731-31737
4. Abassi Z.A., Hoffman A., and Better O.S. Acute renal failure complicating muscle crush injury. Semin. Nephrol. 18 (1998) 558-565
5. Gunther M.R., Sampath V., and Caughey W.S. Potential roles of myoglobin autoxidation in myocardial ischemia-reperfusion injury. Free Radic. Biol. Med. 26 (1999) 1388-1395
6. Holt S., and Moore K. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp. Nephrol. 8 (2000) 72-76
7. D'Agnillo F., and Alayash A.I. A role for the myoglobin redox cycle in the induction of endothelial cell apoptosis. Free Radic. Biol. Med. 33 (2002) 1153-1164
8. Martinez R., Quintana K., Navarro R., Martin C., Hernandez M.L., Aurrekoetxea I., Ruiz-Sanz J.I., Lacort M., and Ruiz-Larrea M.B. Pro-oxidant and antioxidant potential of catecholestrogens against ferrylmyoglobin-induced oxidative stress. Biochim. Biophys. Acta 1583 (2002) 167-175
9. Gibbons G.F., Wiggins D., Brown A.M., and Hebbachi A.M. Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans. 32 (2004) 59-64
10. Rustaeus S., Stillemark P., Lindberg K., Gordon D., and Olofsson S.O. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells. J. Biol. Chem. 273 (1998) 5196-5203
11. Zhou M., Fisher E.A., and Ginsberg H.N. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein. J. Biol. Chem. 273 (1998) 24649-24653
12. Ruiz-Larrea M.B., Garrido M.J., and Lacort M. Estradiol-induced effects on glutathione metabolism in rat hepatocytes. J. Biochem. (Tokyo) 113 (1993) 563-567
13. Pullinger C.R., and Gibbons G.F. Effects of oleate and compactin on the metabolism and secretion of cholesterol and cholesteryl ester by rat hepatocytes. Biochim. Biophys. Acta 713 (1982) 323-332
14. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957) 497-509
15. Ruiz J.I., and Ochoa B. Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis. J. Lipid Res. 38 (1997) 1482-1489
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
17. Vance D.E., Weinstein D.B., and Steinberg D. Isolation and analysis of lipoproteins secreted by rat liver hepatocytes. Biochim. Biophys. Acta 792 (1984) 39-47
18. Martinez R., Navarro R., Martin C., Aurrekoetxea I., Hernandez M.L., Lacort M., Ruiz-Sanz J.I., and Ruiz-Larrea M.B. Doxorubicin increases intracellular diacylglycerol by the mobilization of choline-enriched phospholipids in rat hepatocytes. Ann. N. Y. Acad. Sci. 973 (2002) 49-51
19. Cartoni A., Menna P., Salvatorelli E., Braghiroli D., Giampietro R., Animati F., Urbani A., Del B.P., and Minotti G. Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobin. J. Biol. Chem. 279 (2004) 5088-5099
20. Laranjinha J., Vieira O., Almeida L., and Madeira V. Inhibition of metmyoglobin/H2O2-dependent low density lipoprotein lipid peroxidation by naturally occurring phenolic acids. Biochem. Pharmacol. 51 (1996) 395-402
21. Egawa T., Shimada H., and Ishimura Y. Formation of compound I in the reaction of native myoglobins with hydrogen peroxide. J. Biol. Chem. 275 (2000) 34858-34866
22. Lamb R.G., Koch J.C., and Bush S.R. An enzymatic explanation of the differential effects of oleate and gemfibrozil on cultured hepatocyte triacylglycerol and phosphatidylcholine biosynthesis and secretion. Biochim. Biophys. Acta 1165 (1993) 299-305
23. Chen H.C., and Farese Jr. R.V. DGAT and triglyceride synthesis: a new target for obesity treatment?. Trends Cardiovasc. Med. 10 (2000) 188-192
24. Carrasco M.P., Segovia J.L., and Marco C. Incorporation of exogenous precursors into neutral lipids and phospholipids in rat hepatocytes: effect of ethanol in vitro. Biochem. Pharmacol. 56 (1998) 1639-1644
25. Reeder B.J., Svistunenko D.A., Cooper C.E., and Wilson M.T. The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology. Antioxid. Redox Signal. 6 (2004) 954-966
26. Holt S., Reeder B., Wilson M., Harvey S., Morrow J.D., Roberts L.J., and Moore K. Increased lipid peroxidation in patients with rhabdomyolysis. Lancet 353 (1999) 1241
27. Svistunenko D.A., Dunne J., Fryer M., Nicholls P., Reeder B.J., Wilson M.T., Bigotti M.G., Cutruzzola F., and Cooper C.E. Comparative study of tyrosine radicals in hemoglobin and myoglobins treated with hydrogen peroxide. Biophys. J. 83 (2002) 2845-2855
28. Cooper C.E., Jurd M., Nicholls P., Wankasi M.M., Svistunenko D.A., Reeder B.J., and Wilson M.T. On the formation, nature, stability and biological relevance of the primary reaction intermediates of myoglobins with hydrogen peroxide. Dalton Trans. (2005) 3483-3488
29. Vulcain E., Goupy P., Caris-Veyrat C., and Dangles O. Inhibition of the metmyoglobin-induced peroxidation of linoleic acid by dietary antioxidants: action in the aqueous vs. lipid phase. Free Radic. Res. 39 (2005) 547-563
30. Roy A., Sen S., and Chakraborti A.S. In vitro nonenzymatic glycation enhances the role of myoglobin as a source of oxidative stress. Free Radic. Res. 38 (2004) 139-146
31. Sztiller M., and Puchala M. The influence of metmyoglobin and ferrylmyoglobin on the human erythrocyte membrane. Cell. Mol. Biol. Lett. 8 (2003) 337-342
32. Brito P., Almeida L.M., and Dinis T.C. The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; protection against LDL oxidation. Free Radic. Res. 36 (2002) 621-631
33. Menna P., Salvatorelli E., Giampietro R., Liberi G., Teodori G., Calafiore A.M., and Minotti G. Doxorubicin-dependent reduction of ferrylmyoglobin and inhibition of lipid peroxidation: implications for cardiotoxicity of anticancer anthracyclines. Chem. Res. Toxicol. 15 (2002) 1179-1189
34. Vollaard N.B., Reeder B.J., Shearman J.P., Menu P., Wilson M.T., and Cooper C.E. A new sensitive assay reveals that hemoglobin is oxidatively modified in vivo. Free. Radic. Biol. Med. 39 (2005) 1216-1228
35. Muntane J., Mitjavila M.T., Rodriguez M.C., Puig-Parellada P., Fernandez Y., and Mitjavila S. Dietary lipid and iron status modulate lipid peroxidation in rats with induced adjuvant arthritis. J. Nutr. 125 (1995) 1930-1937
36. Minotti G., Menna P., Salvatorelli E., Cairo G., and Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56 (2004) 185-229
37. Cases S., Stone S.J., Zhou P., Yen E., Tow B., Lardizabal K.D., Voelker T., and Farese Jr. R.V. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J. Biol. Chem. 276 (2001) 38870-38876
38. Cases S., Smith S.J., Zheng Y.W., Myers H.M., Lear S.R., Sande E., Novak S., Collins C., Welch C.B., Lusis A.J., Erickson S.K., and Farese Jr. R.V. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. U. S.A. 95 (1998) 13018-13023
39. Millar J.S., Stone S.J., Tietge U.J., Tow B., Billheimer J.T., Wong J.S., Hamilton R.L., Farese Jr. R.V., and Rader D.J. Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production. J. Lipid Res. 47 (2006) 2297-2305
40. Yamazaki T., Sasaki E., Kakinuma C., Yano T., Miura S., and Ezaki O. Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1. J. Biol. Chem. 280 (2005) 21506-21514
41. Brown A.M., Castle J., Hebbachi A.M., and Gibbons G.F. Administration of n-3 fatty acids in the diets of rats or directly to hepatocyte cultures results in different effects on hepatocellular ApoB metabolism and secretion. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 106-114
42. Waterman I.J., and Zammit V.A. Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities. Diabetes 51 (2002) 1708-1713
43. Gilham D., Alam M., Gao W., Vance D.E., and Lehner R. Triacylglycerol hydrolase is localized to the endoplasmic reticulum by an unusual retrieval sequence where it participates in VLDL assembly without utilizing VLDL lipids as substrates. Mol. Biol. Cell 16 (2005) 984-996
44. Gilham D., Ho S., Rasouli M., Martres P., Vance D.E., and Lehner R. Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion. FASEB J. 17 (2003) 1685-1687
45. Dolinsky V.W., Douglas D.N., Lehner R., and Vance D.E. Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone. Biochem. J. 378 (2004) 967-974
46. Fast D.G., and Vance D.E. Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion. Biochim. Biophys. Acta 1258 (1995) 159-168
47. Verkade H.J., Fast D.G., Rusinol A.E., Scraba D.G., and Vance D.E. Impaired biosynthesis of phosphatidylcholine causes a decrease in the number of very low density lipoprotein particles in the Golgi but not in the endoplasmic reticulum of rat liver. J. Biol. Chem. 268 (1993) 24990-24996
48. Olofsson S.O., Asp L., and Boren J. The assembly and secretion of apolipoprotein B-containing lipoproteins. Curr. Opin. Lipidol. 10 (1999) 341-346
49. Lau P.P., Xiong W.J., Zhu H.J., Chen S.H., and Chan L. Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. J. Biol. Chem. 266 (1991) 20550-20554
50. Fisher E.A., and Ginsberg H.N. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J. Biol. Chem. 277 (2002) 17377-17380
51. Pan M., Cederbaum A.I., Zhang Y.L., Ginsberg H.N., Williams K.J., and Fisher E.A. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J. Clin. Invest. 113 (2004) 1277-1287
52. Jiang X.C., Li Z., Liu R., Yang X.P., Pan M., Lagrost L., Fisher E.A., and Williams K.J. Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. J. Biol. Chem. 280 (2005) 18336-18340
53. Krauss R.M. Hold the antioxidants and improve plasma lipids?. J. Clin. Invest. 113 (2004) 1253-1255
54. Fisher E.A., Pan M., Chen X., Wu X., Wang H., Jamil H., Sparks J.D., and Williams K.J. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J. Biol. Chem. 276 (2001) 27855-27863